Tokyo, Japan

Masahiko Kajii

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Pharma Corporation. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiko Kajii. Retrieved from https://idiyas.com/inventor/masahiko-kajii-8h9nbthy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiko Kajii: Innovator in Medicinal Chemistry

Introduction

Masahiko Kajii is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative research and development of pharmaceutical compounds.

Latest Patents

Kajii holds a patent for "Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products." This invention relates to a novel sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof. More specifically, it focuses on a sulfonic acid derivative that serves as an inhibitor of lipopolysaccharides (LPS). Additionally, the patent includes a novel intermediate compound useful for synthesizing this sulfonic acid derivative.

Career Highlights

Masahiko Kajii is associated with Mitsubishi Pharma Corporation, where he has been instrumental in advancing pharmaceutical research. His work has contributed to the development of new medicinal products that have the potential to improve health outcomes.

Collaborations

Kajii has collaborated with notable colleagues, including Kazuhiro Maeda and Tadahiro Takemoto. These partnerships have fostered a collaborative environment that enhances innovation and research in medicinal chemistry.

Conclusion

Masahiko Kajii's contributions to the field of medicinal chemistry through his patented inventions highlight his role as a key innovator. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…